Literature DB >> 28672297

A Large Adrenal Tumor With Marked 18F-Fluorodeoxyglucose Uptake.

David Taïeb1, Frédéric Sebag2, Karel Pacak3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28672297      PMCID： PMC7440816          DOI： 10.1001/jama.2017.6326

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Berruti; E Baudin; H Gelderblom; H R Haak; F Porpiglia; M Fassnacht; G Pentheroudakis
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

2.  Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?

Authors:  Cord Sturgeon; Wen T Shen; Orlo H Clark; Quan-Yang Duh; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2006-01-18       Impact factor: 6.113

3.  Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

Authors:  S Bovio; A Cataldi; G Reimondo; P Sperone; S Novello; A Berruti; P Borasio; C Fava; L Dogliotti; G V Scagliotti; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

4.  Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.

Authors:  Carole Guerin; François Pattou; Laurent Brunaud; Jean-Christophe Lifante; Eric Mirallié; Magalie Haissaguerre; Damien Huglo; Pierre Olivier; Claire Houzard; Catherine Ansquer; Elif Hindié; Anderson Loundou; Cendrine Archange; Antoine Tabarin; Fréderic Sebag; Karine Baumstarck; David Taïeb
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

5.  Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?

Authors:  L Tessonnier; F Sebag; F F Palazzo; C Colavolpe; C De Micco; J Mancini; B Conte-Devolx; J F Henry; O Mundler; D Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-20       Impact factor: 9.236

Review 6.  Primary adrenal lymphoma: a systematic review.

Authors:  Armin Rashidi; Stephen I Fisher
Journal:  Ann Hematol       Date:  2013-06-15       Impact factor: 3.673

7.  Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.

Authors:  Yuhree Kim; Georgios A Margonis; Jason D Prescott; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Douglas B Evans; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed I Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

8.  18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.

Authors:  Lionel Groussin; Gérald Bonardel; Stéphane Silvéra; Frédérique Tissier; Joël Coste; Gwenaelle Abiven; Rossella Libé; Marie Bienvenu; Jean-Louis Alberini; Sylvie Salenave; Philippe Bouchard; Jérôme Bertherat; Bertrand Dousset; Paul Legmann; Bruno Richard; Hervé Foehrenbach; Xavier Bertagna; Florence Tenenbaum
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

9.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

Review 10.  Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment.

Authors:  Rossella Libé
Journal:  Front Cell Dev Biol       Date:  2015-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.